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Abstract
Introduction
Family history of diabetes has been recognized as an
important risk factor of the disease. Family medical histo-
ry represents valuable genomic information because it
characterizes the combined interactions between environ-
mental, behavioral, and genetic factors. This study exam-
ined the strength and effect of having a family history of
diabetes on the prevalence of self-reported, previously
diagnosed diabetes among adult participants of the
National Health and Nutrition Examination Survey
1999–2002.
Methods
The study population included data from 10,283 partici-
pants aged 20 years and older. Gender, age, race/ethnicity,
poverty income ratio, education level, body mass index,
and family history of diabetes were examined in relation to
diabetes status. Diabetes prevalence estimates and odds
ratios of diabetes were calculated based on family history
and other factors.
Results
The prevalence of diabetes among individuals who have
a first-degree relative with diabetes (14.3%) was signifi-
cantly higher than that of individuals without a family his-
tory (3.2%), corresponding to a crude odds ratio of five.
Both prevalence and odds ratio estimates significantly
increased with the number of relatives affected with dia-
betes. Family history was also associated with several
demographic and risk factors.
Conclusion
Family history of diabetes was shown to be a significant
predictor of diabetes prevalence in the adult U.S. popula-
tion. We advocate the inclusion of family history assess-
ment in public health prevention and screening programs
as an inexpensive and valuable source of genomic infor-
mation and measure of diabetes risk.
Introduction
Diabetes mellitus presents multiple challenges to
public health. An estimated 18.2 million individuals in
the United States have diabetes (1). This disease con-
tributes to significant morbidity, including cardiovascu-
lar, cerebrovascular, and renal disease, and premature
mortality (1-3). In 2002, diabetes was ranked as the
sixth leading cause of death (1,4). Another major public
health challenge is the increasing prevalence of type 2
diabetes in adults, children, and adolescents during the
past two decades (5-7). Additionally, type 2 diabetes
may account for 90% to 95% of all diagnosed cases of
diabetes (1,6,8), may progress undetected for years, and
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is often not diagnosed until onset of clinical symptoms
or complications (3,6,8).
Undiagnosed diabetes constitutes approximately 29.3%
of total diabetes prevalence (5). It is clear that developing
strategies to screen and identify high-risk individuals
should be an important public health goal. Screening for
type 2 diabetes is recommended for individuals aged 45
years and older and/or younger individuals who have one
or more risk factors, such as race/ethnicity (i.e., African
American, Native American, and Hispanic), overweight or
obesity, physical inactivity, previous history of gestational
diabetes, and family history of diabetes (9). A primary goal
of tailored screening is to recognize high-risk individuals
in the presymptomatic stage of diabetes. Research has
indicated that diabetes and many of its health complica-
tions can be delayed or prevented through medical and
lifestyle interventions, such as pharmaceuticals, diet, and
exercise (6,10-17).
For prevention efforts to be most effective, public
health programs must recognize the factors involved in
diabetes susceptibility. Evidence for a strong genetic ele-
ment of type 2 diabetes susceptibility is suggested by the
high incidence in certain racial/ethnic populations
(1,3,6,18,19), high concordance in monozygotic twins
compared with dizygotic twins (6,20,21), and high inci-
dence among first-degree relatives of persons with type
2 diabetes (3,6,19,22-25). The complex pathophysiologic
nature of diabetes supports the idea that multiple bio-
logic and/or chemical pathways are implicated in the
development and progression of the disease (26), and
numerous genetic loci have been investigated in the
search for genetic determinants of the disease (26-30).
Identifying susceptibility loci for diabetes, however, has
been difficult because of the multiple genes involved and
strong environmental contributing factors (26).
Family history of type 2 diabetes is recognized as an
important risk factor of the disease (3,6,9,19,22-25).
Individuals who have a family history of diabetes can have
two to six times the risk of type 2 diabetes compared with
individuals with no family history of the disease (6,19).
The etiologies of type 2 diabetes are complex: family med-
ical history provides valuable genomic information
because it represents the combination of inherited genetic
susceptibilities and shared environmental and behavioral
factors (31). The use of family history as part of a compre-
hensive risk assessment for an individual can be crucial in
the prevention, early detection, and treatment of type 2
diabetes. On a population level, family history may help
tailor health promotion messages for specific population
groups (31).
A goal of this study was to assess the feasibility of
obtaining and using genomic information from an existing,
national population-based data source to provide chronic
disease program recommendations. Specifically, our objec-
tive was to examine the strength and effect of having a
family history of diabetes in first-degree relatives on the
prevalence of self-reported, physician-diagnosed diabetes
among adult participants in the National Health and
Nutrition Examination Survey (NHANES) during 1999 to
2002. We evaluated several risk factors influencing dia-
betes prevalence in the United States and how these fac-
tors relate to family history.
Methods
Population
The National Center for Health Statistics (NCHS), with-
in the Centers for Disease Control and Prevention (CDC),
annually conducts NHANES, a continuous, population-
based survey of the civilian, noninstitutionalized U.S. pop-
ulation (32). Data for NHANES is collected from U.S.
households using two methods: an in-home interview and
a physical health examination. Written informed consent
is obtained from each participant for both parts of the sur-
vey. Information gathered by NHANES is intended for
health research purposes, and NHANES documentation
and codebooks are provided elsewhere (32).
For the study, data sets from both NHANES 1999–2000
and NHANES 2001–2002 were merged to create a
NHANES 1999–2002 data set (n = 21,004) (32).
Information on family history of diabetes was not available
for participants aged 19 years and younger. Because fam-
ily history was considered an important predictor of dia-
betes status, and the main focus was type 2 diabetes, sub-
jects under the age of 20 years (n = 10,713) were excluded
from the data set.
Diabetes status
Diabetes status was self-reported by asking whether an
individual had ever been told by a doctor or health profes-
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than during pregnancy (for female respondents). Because
this survey question precluded gestational diabetes, preg-
nant women (n = 603) were not excluded from the study.
The interview process did not discriminate between type 1
and type 2 diabetes. Survey participants from whom dia-
betes status was not ascertained during the NHANES
interview were excluded from this study (n = 8). Among the
remaining 10,283 adult respondents, 991 were categorized
as having diabetes (including eight pregnant females), and
9292 were categorized as not having diabetes.
Individuals who reported a previous diagnosis of dia-
betes were asked at which age their diagnosis occurred.
Age of diagnosis information was missing for 10 subjects in
the sample population. There were 83 subjects who report-
ed an age of diagnosis younger than 20 years. Although
type 1 diabetes typically occurs during these younger ages,
there was no definitive way to differentiate between type 1
and type 2 diabetes, and therefore we did not exclude any
subject based on age of diabetes diagnosis.
Demographics and risk factors
Gender, age, and race were self-reported during the sur-
vey interview. Age was recorded as the subject’s age in
years at the time of interview. The age categories were
20–39 years, 40–59 years, and 60 years and older (33). Race
and ethnicity were categorized in the following groups: non-
Hispanic white, non-Hispanic black, Mexican American,
and “other,” which consisted of all other individual and
multiracial groups. Statistical results for the “other” cate-
gory are not described because the wide variability within
the group prevents meaningful interpretation of estimates.
Socioeconomic status was assessed by poverty income
ratio (PIR) and education level of the participants. The
PIR, based on family size, is the ratio of family income to
the family’s poverty threshold level, determined by the
Bureau of the Census (34). NHANES calculated partici-
pants’ PIR values using self-reported family income data.
We used the following categories: PIR <1.00, PIR
1.00–1.85, and PIR ≥1.86. PIR values less than 1.00 are
deemed to be below the poverty threshold. Some federally
funded food assistance programs have an eligibility cut
point of 1.85 (33,34). Education level was self-reported as
the highest level achieved and was categorized as less than
high school, high school or general equivalency diploma
(GED), and more than high school.
During the NHANES physical examination, survey par-
ticipants had both standing height (m) and weight (kg)
measured, which were used to calculate body mass index
(BMI [kg/m2]). Healthy weight was defined as BMI <25,
overweight as BMI 25–29, and obesity as BMI ≥30.
Individuals who did not undergo a physical exam or who
had missing BMI information and all women who were
reported as being pregnant at the time of interview were
excluded from analyses that contained BMI.
Family history
Participants were asked whether any biological member
of their family, living or deceased, had ever been told
he/she had diabetes. Family history information was not
available from 216 individuals because of participant
refusal (n = 2) and lack of knowledge of family medical his-
tory (n = 214). Subjects specified the relationship of any
family member with diabetes; however, diabetes in chil-
dren of the participants was not ascertained. We defined
family history as having a first-degree relative (parent
and/or sibling) with diabetes and categorized subjects
according to parental and sibling diabetes status and num-
ber of first-degree relatives with diabetes.
Statistics
Statistical analyses were conducted using SAS version
9.1.3 (SAS Institute Inc, Cary, NC). This newest version
permits analyses of complex survey designs. To achieve
sufficient sample sizes, NHANES oversamples certain
populations (33,34); thus, appropriate NHANES sample
weights, stratums, and primary sampling units (PSUs)
were used to account for complex sampling design, differ-
ential probabilities of selection, and nonresponse.
Poststratification adjustments were applied by NHANES
to the sample weights based on census population con-
trols (33-35).
Prevalence estimates for diabetes, stratified by demo-
graphics and risk factors, were calculated using NHANES
sampling weights and are extrapolated to the adult, non-
institutionalized, civilian U.S. population. Comparisons of
diabetes prevalence between different groups were per-
formed using F tests based on design-adjusted Rao–Scott
chi squares (χ2). Age-adjusted prevalence (not shown) for
the gender–race groups, based on the standard U.S.
Census 2000 population (36), were deemed unreliable
because of large associated standard errors and small sam-
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ple sizes, especially in the group aged 20–39 years. For
subjects with diabetes, the average age at diagnosis was
examined by demographic and risk factors.
Crude and adjusted odds ratios (OR) and 95% confidence
intervals (CI) for diabetes associated with family history
were calculated through logistic regression analyses, which
modeled the binary outcome of diabetes status (yes/no).
Individual Wald  χ2 tests and P values for all  β estimates
were computed. Four regression models were developed to
first analyze family history independently, then in combi-
nation with demographic and risk factors demonstrating
significant association with diabetes status. Variance esti-
mates and standard errors were calculated using the
Taylor expansion method. Any estimate with a relative
standard error greater than 30% was considered to be sta-
tistically unreliable. Significance testing of interaction
terms was performed to assess potential interaction
between the factors included in the models. Likelihood
ratio tests, multivariate Wald  χ2 tests, and F tests were
calculated to test for overall model significance. All P val-
ues less than .05 were considered statistically significant.
Results
Demographics and risk factors
The frequencies and weighted percentages of adults
with diabetes are stratified by demographic and risk 
factors (Table 1). The overall estimated prevalence of dia-
betes among adults, representative of the civilian U.S.
population, was 6.5%. Among men, the diabetes preva-
lence of non-Hispanic black men was significantly 
higher than that of Mexican American men (P = .01). 
Non-Hispanic black women had the highest prevalence of
diabetes (11.4%) among all gender–race groups. The dia-
betes prevalence of non-Hispanic black women was signif-
icantly higher when compared to the prevalence of non-
Hispanic white women (P < .001) and Mexican American
women (P = .007). Mexican American women had signifi-
cantly higher diabetes prevalence than non-Hispanic
white women (P = .004).
The prevalence of diabetes significantly increased with
age at interview (P = .001), and individuals 60 years and
older experienced the highest prevalence (15.1%). Among
the three PIR categories, adults in the group with the
highest PIR level had significantly lower diabetes preva-
lence than adults at poverty level (P = .008) and in the
middle PIR category (P < .001). Additionally, adults with
less than a high school education experienced significant-
ly higher diabetes prevalence than both those with a high
school education (P < .001) and more than a high school
education (P < .001). Finally, diabetes prevalence
increased significantly with higher BMI status (P < .001).
Overweight adults were almost twice as likely to have dia-
betes than healthy-weight adults, and obese adults were
nearly four times as likely than healthy-weight adults.
For the individuals in the study who had diabetes, self-
reported age of diabetes diagnosis was assessed (data not
shown). Among men who had diabetes, the average age of
diagnosis for the three race/ethnicity categories was simi-
lar: 46.4 years (95% CI, 43.3–49.4) for Non-Hispanic
whites, 45.1 years (95% CI, 41.4–48.8) for non-Hispanic
blacks, and 45.0 years (95% CI, 42.1–47.9) for Mexican
Americans. Overall, men with diabetes had a mean age of
diabetes diagnosis of 45.7 years (95% CI, 43.2–48.3). In
contrast, women who had diabetes showed more striking
differences in age of diagnosis among race groups. The
mean age of diagnosis was 48.8 years (95% CI, 44.6–53.0)
for non-Hispanic white women, 43.6 years (95% CI,
41.6–45.6) for non-Hispanic black women, and 40.4 years
(95% CI, 37.5–43.3) for Mexican American women.
Overall, women who had diabetes had an average age at
diagnosis of 46.4 years (95% CI, 43.9–49.0). In addition,
individuals who had diabetes and were obese had a
younger mean age of diabetes diagnosis at 43.7 years (95%
CI, 40.9–46.6) than overweight (48.6 years; 95% CI,
45.8–51.4) and healthy-weight (47.3 years; 95% CI,
44.1–50.4) individuals with diabetes.
Family history
Table 2 displays the frequencies and percentages of indi-
viduals who had diabetes in the study according to family
history status: 3172 adult respondents reported having a
family history of diabetes in a first-degree relative (par-
ents and siblings) within the study population of 10,283.
The diabetes prevalence for individuals with a family his-
tory was more than four times higher than the prevalence
for individuals without a family history (P < .001). Among
adults with a family history, diabetes prevalence increased
significantly with a corresponding increase in number of
family members with diabetes (P < .001). The diabetes
prevalence for individuals with three or more first-degree
relatives with diabetes (44.4%) was higher than the preva-
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Diabetes prevalence associated with parental history
significantly increased with the number of affected par-
ents (P < .001). The diabetes prevalence for individuals
with a diabetic mother (16.5%) was higher than for indi-
viduals with a diabetic father (12.4%). In addition, having
a sibling with diabetes conferred a diabetes prevalence
approximately 4.5 times higher than the prevalence for
individuals without a diabetic sibling (P < .001).
Further assessment of age of diagnosis (data not shown)
showed that among individuals with diabetes who had a
first-degree relative with diabetes, the mean age of diag-
nosis was 44.5 years (95% CI, 42.4–46.6) compared with
48.5 years (95% CI, 45.4–51.6) for individuals with dia-
betes who had no family history of diabetes. Moreover,
there was more than an eight-year difference in mean age
of diagnosis of individuals with diabetes whose parents
had diabetes compared with individuals with diabetes
whose parents did not have diabetes: 39.9 years (95% CI,
34.9–45.0) for individuals with two diabetic parents, 44.3
years (95% CI, 42.1–46.6) for individuals with one diabet-
ic parent, and 48.3 years (95% CI, 45.7–51.0) for individu-
als with neither parent diabetic.
The presence of family history among adults differed by
several factors and is depicted in Figures 1–3. A signifi-
cantly larger proportion of individuals with diabetes
reported having a family history of diabetes than individ-
uals without diabetes (P < .001). More women reported a
family history than men (P = .006). Compared with non-
Hispanic whites, a higher percentage of non-Hispanic
blacks (P = .001) and Mexican Americans (P < .001) report-
ed a family history of diabetes. And obese and overweight
adults were more likely to have a family history of diabetes
than healthy-weight adults (P < .001 for both).
Multivariate analyses
The association of family history and diabetes was eval-
uated with four regression models shown in Table 3. Each
model used a different variable for family history and ana-
lyzed these variables first independently (crude ORs), then
with the addition of other demographic and risk factors in
the model (adjusted ORs). The family history variable was
statistically significant in crude analyses of each model.
Adults with a family history of diabetes had five times the
odds of having diabetes compared with individuals who
did not have a family history of diabetes.
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Figure 1. Percentages (95% confidence interval) of U.S. adults aged 20
years and older reporting a family history of diabetes, by self-reported dia-
betes status, NHANES 1999–2002. 
Figure 2. Percentages (95% confidence interval) of U.S. adults aged 20
years and older reporting a family history of diabetes, by gender and
race/ethnicity, NHANES 1999–2002.
Figure 3. Percentages (95% Confidence IntervaI) of U.S. adults aged 20
years and older reporting a family history of diabetes, by body mass index
(BMI), NHANES 1999–2002.VOLUME 2: NO. 2
APRIL 2005
The adjusted models used the categorical factors of gen-
der, age group, race/ethnicity, PIR, and BMI. Since PIR
and education level were highly related, education level
was not included in the models. Regression analyses were
also performed using age, PIR, and BMI as continuous
variables; however, this did not appreciably change the
parameter estimates corresponding to family history. In
each of the four models, all additional variables were sta-
tistically significant, with the exception of BMI 25–29, for
which the    β estimate had a P value of .051 (Model 1) and
.052 (Model 2).
After adjusting for the other variables, family history
remained significantly associated with diabetes status,
though the adjusted ORs were slightly lower than the
crude ORs. Adults with a family history of diabetes had
four times the odds of having diabetes themselves com-
pared with individuals without a family history (P < .001).
The odds of having diabetes were almost 15 times higher
for those with three or more diabetic relatives compared
with adults with no family history (P < .001). Parental and
sibling diabetes history were also significantly associated
with increased risk of diabetes (P < .001 for both).
Discussion
Our diabetes prevalence estimates for the gender–race
groups were similar to a previous review of data from
NHANES III (1988–1994), which showed that for both
men and women, non-Hispanic blacks had a higher dia-
betes prevalence than non-Hispanic whites and Mexican
Americans (37). However, we did not find any studies
using NHANES data that examined family history of dia-
betes in relation to diabetes prevalence.
We found that family history of diabetes was a signifi-
cant predictor of self-reported diabetes among U.S. adults.
We estimated that adults with a family history of diabetes
in a parent or sibling had four times the odds of having
diabetes than adults without a family history of the dis-
ease, after adjusting for gender, age, race, PIR, and BMI.
These findings are consistent with a recent summary
review of 10 studies performed in various countries, which
reported that individuals with a positive family history of
diabetes had two to six times the risk of type 2 diabetes,
compared with individuals without a family history of 
the disease (19).
Moreover, our study demonstrated that adults with two
diabetic parents had more than twice the risk of diabetes
than adults with only one diabetic parent. This additive
risk association has been described previously in a white
U.S. population (22). Through further examination of fam-
ily history, an elevated diabetes risk was found to be asso-
ciated with an increased number of first-degree family
members affected with diabetes. Among all demographic
and risk factors, the presence of three or more diabetic
first-degree relatives corresponded to the highest diabetes
prevalence and OR for diabetes. With the exception of a
few studies, a relatively small amount of literature quan-
tified family history of diabetes in terms of the number of
affected relatives.
Because family history was one of the strongest risks for
diabetes in our study, individuals with family members
who have diabetes should be a screening priority for 
diabetes. As stated previously, undiagnosed diabetes con-
stitutes approximately 29.3% of total diabetes prevalence
(5). A current study demonstrated that the prevalence of
diagnosed diabetes has increased, and the prevalence of
undiagnosed diabetes has decreased for severely obese
individuals (BMI ≥35), possibly because of a better aware-
ness of BMI as a risk factor among health care providers
and improved screening among these individuals (5).
Similarly, the use of a family history screening tool could
capture many more of these undiagnosed individuals who
would benefit from early intervention.
Individuals who have close relatives with diabetes may
be more motivated to seek early health screening and thus
more likely to be diagnosed than individuals without a
family history. Because of earlier screening, individuals
with a family history would likely be younger at age of
diagnosis than individuals without a family history. This
likelihood is supported by both our study (44.5 years at
diagnosis for individuals with a family history vs 48.5
years at diagnosis for individuals without a family history)
and an Australian study, which found a trend of younger
age of diabetes diagnoses with increasing number of fami-
ly members affected (24). Furthermore, research has
shown that individuals with type 2 diabetes are more like-
ly to collect health information from family members (38).
However, our study indicated that a higher proportion of
adults who had diabetes did not know their family history
of diabetes (2.7%) when compared with adults who did not
have diabetes (2.0%), although this difference was not 
statistically significant.
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father, mother, brother, or sister with diabetes than men,
and there were more reports of female relatives with dia-
betes than male relatives with diabetes. A recent study
found that women were slightly more likely than men to
regard family history as very important to their own health
and were more likely to collect family medical information
(38). Among men in our study, 2.2% did not know their
family history of diabetes, compared with 1.8% of women.
Limitations
Limitations of our study include the inability to discrim-
inate between cases of type 1 and type 2 diabetes. Had
stratification been possible, we may have found different
relationships among diabetes, family history, and other
factors. Subjects in our study were not excluded based on
age of diabetes diagnosis; such exclusion could have elimi-
nated many type 1 diabetes cases. It is estimated that
approximately one third of children with diabetes aged 12
to 19 years have type 1 diabetes. The prevalence of type 1
diabetes among all ages in the United States is approxi-
mately 0.12% (39). Therefore, the exclusion of individuals
with type 1 diabetes from our study population would
probably not have affected our results appreciably.
Because diabetes diagnoses of participants and family
members were self-reported and not verified, the true dia-
betes prevalence may be misrepresented. Moreover, dia-
betes is underdiagnosed in the United States, suggesting
that the true prevalence is higher than reported preva-
lence. Subjects also self-reported age of diabetes diagnosis,
creating a potential for recall bias. As previously men-
tioned, survey participants were not asked about family
history of diabetes in children, which limited our definition
of first-degree relatives to parents and siblings only. Also,
NHANES excludes institutionalized persons, including
individuals residing in nursing homes, who are likely to be
older adults.
Implications
Our findings create several implications for public
health. First, diabetes has paralleled the obesity epidemic.
Similar to a previous NHANES study (40), we found that
non-Hispanic black women had the highest prevalence of
obesity (48.7%) compared with non-Hispanic white women
(31.1%), Mexican American women (36.8%), non-Hispanic
black men (26.8%), non-Hispanic white men (27.9%), and
Mexican American men (25.8%). The prevalence of family
history was also highest in women and non-Hispanic
blacks among genders and races. Both obesity and dia-
betes have strong environmental components, such as diet
and physical activity. Thus, the presence of family history
often reflects the shared environment and health-related
behaviors among family members in addition to heredi-
tary factors. The recognition of this high correlation among
obesity, diabetes, and family history can help guide popu-
lation-appropriate health promotion activities.
Second, with the current striving for genetic awareness
and competency in public health, this study represents a
feasible and inexpensive method of extracting genomic
information from existing population-based data sources.
NHANES, a validated and well-recognized survey, pro-
vides a substantial amount of health information on a
national level. Other population-based surveys also offer
informative data that may pertain to genomics. There are
several steps public health practitioners can take now to
access and use genomics and incorporate genomics into
programs. Because family history encompasses both
genetic and environmental factors, it can be applied to
other chronic diseases involving multiple complex etiolo-
gies, such as cardiovascular disease. Therefore, knowledge
gained from family history and diabetes can be translated
into other public health program areas.
Finally, at the primary care and public health level, this
study supports the promotion of a family history tool for
diabetes prevention and early detection strategies as a
valuable measure of diabetes risk. Family history is easily
available and inexpensive to obtain yet may be underused
in health care practice (31). The following three criteria
are suggested for incorporating a family history tool into
public health screening: 1) the disease represents a signif-
icant public health burden, 2) family history is an estab-
lished risk factor, and 3) there are effective interventions
for prevention (31). Type 2 diabetes meets these criteria. It
is evident that neither diabetes nor obesity prevalence is
decreasing; therefore, it is critical that we use all available
resources to quantify individual disease risk as accurately
and completely as possible.
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Tables
Table 1. Frequencies and Percentages of Self-Reported Individuals With Diabetes by Demographic and Risk Factors, Adults
Aged 20 Years and Older in the United States, 1999–2002
Total 10,283 991 6.5 (5.9-7.1)
Men
All races 4802 481 6.7 (5.9-7.5)
Non-Hispanic white 2396 196 6.2 (5.1-7.3)
Non-Hispanic black 887 108 8.2 (6.5-9.9)
Mexican American 1129 130 5.3 (3.9-6.7)
Women
All races 5481 510 6.3 (5.5-7.2)
Non-Hispanic white 2674 170 5.1 (4.4-5.8)
Non-Hispanic black 1034 140 11.4 (9.2-13.6)
Mexican American 1266 148 7.7 (6.2-9.3)
Age, years
20-39 3618 61 1.7 (1.1-2.2)
40-59 2964 256 6.6 (5.6-7.5)
>60 3701 674 15.1 (13.9-16.4)
Poverty income ratio (PIR)
PIR <1.00 (poverty) 1743 208 7.9 (6.0-9.8)
PIR 1.00-1.85 2138 278 8.7 (7.3-10.1)
PIR >1.86 5222 378 5.3 (4.7-6.0)
Education level
Less than high school 3559 514 10.9 (9.5-12.3)
High school/GED 2361 200 6.5 (5.4-7.5)
More than high school 4321 273 4.7 (3.8-5.5)
Total (n) Diabetic (n) Weighteda % (95% CI)
(Continued on next page)Table 1. (continued) Frequencies and Percentages of Self-Reported Individuals With Diabetes by Demographic and Risk
Factors, Adults Aged 20 Years and Older in the United States, 1999–2002
Body mass index (BMI)b
BMI <25 2752 143 3.1 (2.3-3.9)
BMI 25-29 3087 298 5.9 (4.8-7.0)
BMI >30 2662 386 11.2 (10.1-12.4)
aFor extrapolation of diabetes prevalence to the adult, noninstitutionalized, civilian U.S. population, weighted percentages incorporate NHANES sampling
weights to account for unequal selection probabilities and nonrandom sampling design. 
bExcludes pregnant women.
Table 2.  Frequencies and Percentages of Self-Reported Individuals With Diabetes by Family History of Diabetes, Adults Aged
20 Years and Older in the United States, 1999–2002
Family history of diabetes (parents and/or siblings only)
No 6895 344 3.2 (2.8-3.6)
Yes 3172 618 14.3 (12.8-15.9)
Number of relatives with diabetes (parents and/or siblings only)
One relative 2343 354 11.0 (9.5-12.5)
Two relatives 606 148 19.3 (15.4-23.2)
Three or more relatives 223 116 44.4 (37.7-51.0)
Parental history of diabetes
Neither parent has diabetes 7640 512 4.2 (3.7-4.7)
One parent has diabetes 2181 368 12.3 (10.7-13.9)
Both parents have diabetes 246 82 25.4 (18.8-31.9)
Father has diabetes 1046 177 12.4 (10.0-14.7)
Mother has diabetes 1627 355 16.5 (14.6-18.5)
Sibling history of diabetes
No sibling has diabetes 8749 596 4.7 (4.2-5.2)
At least one sibling has diabetes 1318 366 21.7 (19.2-24.3)
Brother(s) has/have diabetes 756 228 23.3 (19.7-26.9)
Sister(s) has/have diabetes 828 257 25.6 (22.2-28.9)
aFamily history status was not ascertained for 216 of the 10,283 participants in the National Health and Nutrition Examination Survey 1999–2002.
bFor extrapolation of diabetes prevalence to the adult, non-institutionalized, civilian U.S. population, weighted percentages incorporate NHANES sampling
weights to account for unequal selection probabilities and nonrandom sampling design.
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Total (n) Diabetic (n) Weighteda % (95% CI)
Total (n)a Diabetic (n) Weightedb % (95% CI)VOLUME 2: NO. 2
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Table 3. Odds Ratios and 95% Confidence Intervals for Diabetes by Family History, Adults Aged 20 Years and Older in the
United States, 1999–2002a
Model 1: Family history of diabetes (parents and/or siblings only)c
No 1.00 (ref) NA 1.00 (ref) NA
Yes 5.06 4.37-5.85 3.95 3.25-4.79
Model 2: Number of relatives with diabetes (parents and/or siblings only)c
None 1.00 (ref) NA 1.00 (ref) NA
One relative 3.74 3.15-4.43 3.05 2.44-3.82
Two relatives 7.25 5.63-9.34 5.14 3.81-6.91
Three or more relatives 24.12 18.24-31.89 14.83 10.95-20.08
Model 3: Parental history of diabetesc
No 1.00 (ref) NA 1.00 (ref) NA
One parent has diabetes 3.17 2.65-3.79 3.04 2.34-3.94
Both parents have diabetes 7.68 5.63-10.48 6.95 4.69-10.29
Model 4: Sibling history of diabetesc
No 1.00 (ref) NA 1.00 (ref) NA
At least one sibling has diabetes 5.59 4.80-6.51 3.52 2.94-4.21
aOR indicates odds ratio; CI indicates confidence interval; ref indicates referent group; NA indicates not applicable. 
bFull regression models are adjusted for gender (males, females), age group (20–39, 40–59, >60 years), race/ethnicity (non-Hispanic white, non-Hispanic
black, Mexican American, other), poverty income ratio (PIR) (PIR <1.00, PIR 1.00–1.85, PIR >1.86), and body mass index (BMI <25, BMI 25–29, BMI
>30). Females, aged 20–39 years, non-Hispanic white, PIR >1.86, and BMI <25 were used as referent groups. 
cOverall model significance: P < .001.
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Crude Adjustedb
Model OR 95% CI OR 95% CI